In the third installment in our podcast series, we chat with new Addgene Board Member, Michael Koeris. Dr. Koeris did his graduate work in Professor Jim Collins' lab (then at Boston University, now at MIT) where he worked on understanding bacterial antibiotic resistance. During this time, Dr. Koeris and Professor Timothy Lu (a graduate student in the Collins' lab at the time) got the idea to engineer bacteriophage (viruses that infect bacteria) for use as antibiotics. To develop this idea, Drs. Koeris and Lu founded the biotech startup company, Novophage. As you'll hear Dr. Koeris explain however, the time was not right for the development of phage-based therapeutics. After a brief stint at the venture capital firm, Flagship Ventures, Koeris helped change Novophage's focus. The company went from developing therapeutics to developing phage-based tools for detecting pathogens in food products. Along the way, the company changed its name from Novophage to Sample 6.